All Stories

  1. Re: Therapy-related acute myeloid leukemia and myelodysplastic syndrome among refractory germ cell tumor patients
  2. Acute kidney injury caused by systemic Neisseria gonorrhoeae infection after successful kidney transplantation
  3. Editorial Comment to Assessing perioperative, functional and oncological outcomes of patients with imperative versus elective indications for robot-assisted partial nephrectomy: Results from a high-volume center
  4. Editorial Comment to Implication of aortic calcification on persistent hypertension after laparoscopic adrenalectomy in patients with primary aldosteronism
  5. Identification of a subgroup with worse prognosis among patients with poor-risk testicular germ cell tumor
  6. MP79-16 HEAT SHOCK PROTEIN 90 IS A POTENTIAL NEW BIOMARKER OF SEVERE ACUTE REJECTION AFTER RENAL TRANSPLANTATION
  7. 520 Expression of hepatocyte growth factor in prostate cancer may indicate a biochemical recurrence after radical prostatectomy
  8. The potential of neurotensin secreted from neuroendocrine tumor cells to promote gelsolin-mediated invasiveness of prostate adenocarcinoma cells
  9. MP60-01 INCIDENCE AND RISK FACTORS FOR ACUTE KIDNEY INJURY AFTER RADICAL CYSTECTOMY
  10. Editorial Comment to Prediction of partial nephrectomy outcomes by using the diameter-axis-polar nephrometry score
  11. P032 Preclinical study of a novel immunotherapy for renal cell carcinoma: Combination of long and short peptides
  12. 297 ESTABLISHMENT OF A RENAL CELL CARCINOMA CELL LINE ASSOCIATED WITH TFE3 GENE FUSIONS
  13. 214 PROSTATE CANCER STEM-LIKE CELLS/CANCER INITIATING CELLS HAVE AN AUTOCRINE SYSTEM OF HEPATOCYTE GROWTH FACTOR
  14. 603 Heat shock protein 90 is involved in antibody-mediated rejection and is a potential target of anti-rejection therapy in kidney transplantation
  15. 337 Clinicopathological characteristics of Xp11 translocation renal cell carcinoma in adults: Diagnosis using FISH analysis in conjunction with TFE3 immunostaining
  16. Evaluation of long-term outcome for patients with renal cell carcinoma after surgery: analysis of cancer deaths occurring more than 10 years after initial treatment
  17. Editorial Comment from Dr Tanaka to Risk factors for chronic kidney disease after chemotherapy for testicular cancer
  18. 199 PHD3 expression is a predictor of progression-free survival in clear cell renal cell carcinoma
  19. 663 Phase I clinical study of survivin-derived peptide vaccine with interferon alpha therapy for advanced urothelial cancer
  20. Clinical outcomes of surgical treatment and longitudinal non-surgical observation of patients with subclinical Cushing′s syndrome and nonfunctioning adrenocortical adenoma
  21. UP-01.178 Does Multidetector Row Computed Tomography Improve Accuracy in T Staging of Upper Urinary Tract Urothelial Carcinoma?
  22. Animal model for the study of the relationship between lower urinary tract symptoms/bladder outlet obstruction and erectile dysfunction
  23. 671 A ROLE FOR PREOPERATIVE SYSTEMIC CHEMOTHERAPY IN NODE-POSITIVE UPPER TRACT UROTHELIAL CARCINOMA TREATED WITH RADICAL NEPHROURETERECTOMY: A RETROSPECTIVE EXPERIENCE
  24. 1278 NEUROENDOCRINE CELL-CANCER INTERACTION INDUCED BY EGF PROMOTES GELSOLIN-MEDIATED INVASION OF PROSTATE CANCER CELLS
  25. 354 PHD3 HAS A HIF-INDEPENDENT-ANTIPROLIFERATIVE FUNCTION IN RENAL CELL CARCINOMA
  26. Cytomegalovirus infection following renal transplantation in patients administered low-dose rituximab induction therapy
  27. ESTABLISHMENT OF A MANAGEMENT PROTOCOL FOR SUBCLINICAL CUSHING SYNDROME AND NONFUNCTIONING ADERENOCORTICAL ADENOMA
  28. EXPRESSION OF HYPOXIA-INDUCIBLE FACTOR IN RENAL CELL CARCINOMA IS INDEPENDENT OF VON-HIPPEL LINDAU PROTEIN INACTIVATION
  29. Renal transplantation after myeloablative and non-myeloablative hematopoietic cell transplantation from the same donor
  30. Effects of a new immunosuppressive agent, β-SQAG9, in swine kidney transplantation
  31. Retroperitoneal extragonadal germ cell tumor presenting as a bulky pelvic mass of the obturator fossa
  32. Testicular metastasis from squamous cell carcinoma of the lung